Reports for SANOFI-AVENTIS CANADA INC
Company Name SANOFI-AVENTIS CANADA INC |
||
|---|---|---|
Totals |
||
Shortage reports |
281 |
|
| Actual shortage: | 5 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 260 (93%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 7 (12%) | |
| Discontinued: | 51 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
22 (6%) |
|
Overdue reports |
9 (75%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2022-03-16 | 2022-07-12 | 156783 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2023-07-19 | 2023-07-21 | 199221 |
| RENAGEL | 800MG | TABLET | Actual shortage | 2025-04-17 | 2025-05-12 | 255211 |
| RENVELA | 800MG | TABLET | Resolved | 2019-01-04 | 2019-01-10 | 71284 |
| RENVELA | 800MG | TABLET | Resolved | 2024-02-16 | 2024-05-15 | 219863 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Resolved | 2024-07-26 | 2025-04-03 | 233720 |
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Resolved | 2024-10-22 | 2025-04-03 | 240885 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2019-05-28 | 2019-10-15 | 84937 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2021-02-16 | 2021-05-22 | 134202 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2023-10-30 | 2024-02-23 | 208624 |
| RIFADIN | 150MG | CAPSULE | Resolved | 2018-01-10 | 2018-02-02 | 35644 |
| RIFADIN | 150MG | CAPSULE | Resolved | 2019-03-22 | 2021-02-16 | 79293 |
| RIFADIN | 300MG | CAPSULE | Resolved | 2019-03-22 | 2021-02-16 | 79314 |
| RILUTEK | 50MG | TABLET | Resolved | 2019-11-14 | 2021-09-29 | 98763 |
| SECTRAL | 100MG | TABLET | Resolved | 2018-05-08 | 2018-07-31 | 48844 |
| SECTRAL | 200MG | TABLET | Resolved | 2018-04-18 | 2018-07-27 | 46276 |
| SOLIQUA | 33MCG 100UNIT | SOLUTION | Resolved | 2022-07-22 | 2022-08-04 | 165375 |
| TALWIN | 50MG | TABLET | Resolved | 2018-08-14 | 2019-04-03 | 58104 |
| THYMOGLOBULIN | 25MG | POWDER FOR SOLUTION | Avoided shortage | 2019-01-28 | 2019-03-22 | 73721 |
| THYROGEN | 0.9MG | POWDER FOR SOLUTION | Resolved | 2022-01-13 | 2022-02-08 | 152688 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| FLAGYL | 10% | CREAM | Discontinued | 2024-03-28 | 2024-11-20 | 223877 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| MOZOBIL | 20MG | SOLUTION | To be discontinued | 2025-03-31 | 2025-03-31 | 253686 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98371 |
| NOVAHISTINE DH | 10MG 1.7MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98377 |
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |